1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Cancer Drug News 28 SEPTEMBER 2015

Cancer Drug News 28 SEPTEMBER 2015

  • September 2015
  • -
  • Espicom Business Intelligence
  • -
  • 12 pages

Industry Trend Analysis - Crowdsourcing Gaining Traction As Novel Pharmaceutical Innovation Tool
Industry Brief - Amgen Receives CHMP Positive Opinions For Two Haematological Cancer Drugs
Industry Brief - CHMP Grants Accelerated Assessment For Daratumumab In Double Refractory Multiple Myeloma
Industry Brief - CHMP Recommends Expanded Indication For Celgene's Vidaza
Industry Trend Analysis - Otsuka's Long-Term Oncology Position Lies Beyond Current Portfolio
Industry Brief - FDA Grants Priority Review For Opdivo+Yervoy In Untreated Advanced Melanoma
Industry Brief - CHMP Adopts Positive Opinion for Cobimetinib in Combination For Advanced Melanoma
Industry Brief - MedImmune/3M Partner To Develop Novel TLR Agonist Cancer Therapies
Industry Brief - Leuplin 24-Week Depot Approved In Japan
Industry Brief - Pfizer Exercises Option To Advance Accurin Candidate
Industry Trend Analysis - Amgen And Allergan's Biosimilar Bevacizumab On Target For Blockbuster Status
Industry Trend Analysis - Large Unmet Medical Need To Provide Limited Commercial Opportunities
Industry Trend Analysis - AstraZeneca Positioning Itself As Key ADC Player

Table Of Contents

Cancer Drug News 28 SEPTEMBER 2015

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Monoclonal Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

Monoclonal Antibody Therapeutics Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • January 2017
  • by Transparency Market Research

Global Monoclonal Antibody Therapeutics Market: Overview Monoclonal antibodies are a type of biological therapy used in the treatment serious conditions such as cancer, rheumatoid arthritis, Crohn’s ...

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

Immunotherapy Drugs Market by Type of Drugs, Therapy Area, End-User, Region - Global Forecast to 2021

  • $ 5650
  • Industry report
  • January 2017
  • by MarketsandMarkets

The global immunotherapy drugs market is projected to reach USD 201.52 billion by 2021 from USD 108.41 billion in 2016, growing at a CAGR of 13.5% during the forecast period of 2016 to 2021. In this report, ...

Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments

Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments

  • $ 4995
  • Industry report
  • December 2016
  • by GBI Research

Global Neurodegenerative Drugs Market to 2022 - Growth Driven by an Aging Population, the Approval of Novel Immunomodulators and Neuromodulators, and Strong Uptake of Marketed Anti-Inflammatory Treatments ...


Download Unlimited Documents from Trusted Public Sources

Insulin Market and Diabetes Statistics in the US

  • February 2017
    8 pages
  • Insulin  

    Antidiabetics  

    Diabetes  

  • United States  

View report >

Hormone Market in the US

  • February 2017
    9 pages
  • Hormone  

    Cytokine  

  • United States  

View report >

Therapy Market and Monoclonal Antibody Market in Japan

  • February 2017
    6 pages
  • Therapy  

    Monoclonal Anti...  

  • Japan  

View report >

Related Market Segments :

Monoclonal Antibody

ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.